NCT06429215

Brief Summary

Older adults with subjective cognitive decline (SCD) are at high risk of developing dementia and frequently experience subclinical symptoms (e.g., anxiety, depression) which are themselves associated with dementia and cognitive decline risk. To date, the lack of effective disease-modifying treatments, along with the reliable identification of modifiable lifestyle risk factors (e.g., cognitive activity, dietary habits, physical exercise), have led to growing interest to invest in non-pharmacological interventions that may reduce the prevalence and incidence of dementia and cognitive decline in older adults. In this framework, the aim of this project is to evaluate the efficacy of an Immersive Virtual Reality (IVR) and telemedicine-based multi-component intervention, combining cognitive training and a health and lifestyle education program, for preventing cognitive decline and dementia in at-risk individuals (i.e., SCD). For this purpose, a randomized, double-blinded controlled trial (RCT) will be conducted on seventy-five eligible individuals with SCD, who will be randomly assigned to one of three conditions: (a) multi-component intervention (MC-I), including SCD-tailored cognitive IVR training plus a health and lifestyle education program, (b) cognitive-only intervention (CO-I), including the SCD-tailored cognitive IVR training plus an active control for the education program, and (c) active control intervention (AC-I) for both cognitive training and education program. Intervention will be provided in 20 at-home sessions (4 sessions/week, each lasting about 30 minutes) over a period of 5 weeks. Outcome measures include clinical, neuropsychological, behavioural and neuroimaging data that will be collected before and immediately after intervention in order to detect potentially intervention-induced changes in objective cognitive functioning (primary outcome), subjective cognitive functioning, mood, quality of life and brain connectivity (secondary outcome). Users' compliance with IVR and telemedicine approach will be also evaluated, as well as individuals' factors affecting training efficacy.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
75

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jul 2024

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 10, 2024

Completed
14 days until next milestone

First Posted

Study publicly available on registry

May 24, 2024

Completed
1 month until next milestone

Study Start

First participant enrolled

July 1, 2024

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2025

Completed
7 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2025

Completed
Last Updated

October 1, 2024

Status Verified

September 1, 2024

Enrollment Period

10 months

First QC Date

May 10, 2024

Last Update Submit

September 30, 2024

Conditions

Keywords

Subjective cognitive declineMulti-component trainingNon-pharmacological interventionVirtual realityTelemedicine

Outcome Measures

Primary Outcomes (3)

  • Cognitive functioning (1): change scores on the Face-Name Associative Memory Exam

    The Face-Name Associative Memory Exam (short form - FNAME12) is an associative long-term memory task that requires the participant to learn and retrieve 12 novel face-name and face-occupation pairs. It consists of two learning phases, followed by an immediate cued recall and a 30-min delayed recall and recognition trial. For each trial, scores range from 0 to 12, where higher scores indicate better memory performance.

    Baseline, post-intervention (around 6 weeks after baseline)

  • Cognitive functioning (2): change scores on the Visual Short-Term Memory Binding Test

    The Visual Short-Term Memory Binding Test is a recognition task based on a change detection paradigm for arrays of stimuli presented on a computer screen. Two conditions are investigated, that is, a shape-only condition as the first and a shape-color condition as the second. In both conditions, participants are asked to remember visual arrays of two or three black polygons (in the shape-only condition) or colored polygons (in the shape-color condition) presented for 2 s (study phase). For each condition, scores range from 0 to 32, where higher scores indicate better memory performance.

    Baseline, post-intervention (around 6 weeks after baseline)

  • Cognitive functioning (3): change scores on the Spatial pattern separation test

    The Spatial pattern separation test assesses the ability to differentiate partially overlapping patterns of activation in order to retrieve one pattern as separate from others that are similar. Specifically, it consists of 36 trials, in which the participant is required to learn the location of a grey circle on a sceen; then the participant is required to recognize the position of the previously-learned grey circle with respect to a foil located either to the left or the right of the target. Scores range from 0 to 36, where higher scores indicate better memory performance.

    Baseline, post-intervention (around 6 weeks after baseline)

Secondary Outcomes (6)

  • Transfer effect on self-perceived cognitive functioning: change scores on the Subjective Memory Complaints Questionnaire

    Baseline, post-intervention (around 6 weeks after baseline)

  • Intervention-induced changes in whole-brain functional connectivity

    Baseline, post-intervention (around 6 weeks after baseline)

  • Transfer effect on mood (1): change scores on the 30-item Geriatric Depression Scale

    Baseline, post-intervention (around 6 weeks after baseline)

  • Transfer effect on mood (2): change scores on the State-Trait Anxiety Inventory

    Baseline, post-intervention (around 6 weeks after baseline)

  • Transfer effect on mood (3): change scores on the 18-item Apathy Evaluation Scale (AES)

    Baseline, post-intervention (around 6 weeks after baseline)

  • +1 more secondary outcomes

Study Arms (3)

Multi-component Intervention (MC-I)

EXPERIMENTAL

VR cognitive training + Psychoeducation program

Device: Multi-component Intervention (MC-I): VR Cognitive training and Psychoeducation on health and lifestyle

Cognitive-only intervention (CO-I)

ACTIVE COMPARATOR

VR Cognitive training + Psychoeducation active control

Device: Cognitive-only intervention (CO-I): VR Cognitive training (+ Psychoeducation active control)

Active control intervention (AC-I)

ACTIVE COMPARATOR

VR Cognitive active control + Psychoeducation active control

Device: Active control intervention (AC-I): VR Cognitive active control + Psychoeducation active control

Interventions

In a period of 5 consecutive weeks, participants will receive: * an interactive immersive virtual reality cognitive training for 30 minutes, 3 days per week. It consists in different tasks implemented in virtual real-like scenarios of daily living situations that target the following cognitive processes: long-term associative memory, relational binding, spatial pattern separation and pattern completion; * an interactive immersive virtual reality health and lifestyle education program for 30 minutes, 1 day per week. It consists in 360° videos aimed at advancing awareness and knowledge of the various health conditions associated with an increased risk of cognitive decline and dementia and helping participants to develop a healthier lifestyle.

Multi-component Intervention (MC-I)

In a period of 5 consecutive weeks, participants will receive: * the interactive immersive virtual reality cognitive training as described in the MC-I condition, for about 30 minutes, 3 days per week; * an active control of the immersive virtual reality psychoeducation program for 30 minutes, 1 day per week.

Cognitive-only intervention (CO-I)

In a period of 5 consecutive weeks, participants will receive: * an active control of the immersive virtual reality cognitive training (participants will be requested to virtually carry out daily actions, in the same setting as those performed in cognitive immersive VR training, but they will follow prearranged instructions requiring very low cognitive demands) for about 30 minutes, 3 days per week; * an active control of the immersive virtual reality psychoeducation program for about 30 minutes, 1 day per week.

Active control intervention (AC-I)

Eligibility Criteria

Age55 Years - 80 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Self-perceived decline in cognition compared to five years ago
  • Lack of objective cognitive impairment.

You may not qualify if:

  • Clinically significant depression and anxiety;
  • Psychiatric disorders;
  • Unstable medical conditions.
  • Severe visual, auditory, verbal or physical impairments interfere with communication, command compliance, and strategy execution
  • Dizziness or epilepsy history;

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

I.R.C.C.S Santa Lucia Foundation

Rome, Lazio, 00179, Italy

RECRUITING

Related Publications (1)

  • De Simone MS, Zabberoni S, Costa A, Tenaglia E, Tieri G. The effects of an immersive virtual reality and telemedicine-based multi-component intervention in individuals with subjective cognitive decline: study protocol of a randomized controlled trial. Front Psychol. 2025 Jul 11;16:1591239. doi: 10.3389/fpsyg.2025.1591239. eCollection 2025.

Central Study Contacts

Maria Stefania De Simone, Dr

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal investigator

Study Record Dates

First Submitted

May 10, 2024

First Posted

May 24, 2024

Study Start

July 1, 2024

Primary Completion

May 1, 2025

Study Completion

December 1, 2025

Last Updated

October 1, 2024

Record last verified: 2024-09

Locations